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Neurotrophins are important modulators of epithelial–mesenchymal interactions. Previously, we had shown that
brain-derived neurotrophic factor (BDNF) and its high-afﬁnity receptor tyrosine kinase B (TrkB) are prominently
involved in the control of murine hair follicle cycling. We now show that BDNF and TrkB are also expressed in the
human hair follicle in a manner that is both hair cycle dependent and suggestive of epithelial–mesenchymal cross-
talk between BDNF-secreting dermal papilla ﬁbroblasts of anagen hair follicles and subpopulations of TrkBþ hair
follicle keratinocytes. As functional evidence for an involvement of BDNF/TrkB in human hair growth control, we
show in organ-cultured human anagen hair follicles that 50 ng per mL BDNF significantly inhibit hair shaft elon-
gation, induce premature catagen development, and inhibit keratinocyte proliferation. Quantitative real-time rtPCR
analysis demonstrates upregulation of the potent catagen inducer, transforming growth factor b2 (TGFb2) by BDNF,
whereas catagen induction by BDNF was partially reversible through co-administration of TGFb-neutralizing an-
tibody. This suggests that TrkB-mediated signaling promotes the switch between anagen and catagen at least in
part via upregulation of TGFb2. Thus, human scalp hair follicles are both a source and target of bioregulation by
BDNF, which invites to target TrkB-mediated signaling for therapeutic hair growth modulation.
Key words: brain-derived neurotrophic factor/hair cycle/human/neurotrophin/tumor growth factor b2/tyros-
inekinase B
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Since its discovery more than 20 y ago (Barde et al, 1982),
the neurotrophin brain-derived neurotrophic factor (BDNF),
the second member of the nerve growth factor family of
growth factors, has become known to guide and sustain
sensory and autonomic neuron development and their dif-
ferentiation within peripheral neural networks (Barde et al,
1982; Botchkarev et al, 1998b; Ernfors, 2001; Metsis, 2001;
Farinas et al, 2002). BDNF is produced by peripheral inner-
vation targets such as visceral epithelia (Lommatzsch et al,
1999) and skin including the murine and rat hair follicle
(Botchkarev et al, 1999a, b; Bergman et al, 2000; Peters
et al, 2003) and cutaneous nerve fibers express the high-
affinity receptor for BDNF tyrosine kinase B (TrkB) in mice
(Botchkarev et al, 1999a) and humans (Peters et al, 2003).
As a result of more recent research efforts, neurotrophins
such as BDNF have also been shown to hold growth- and
immunmodulatory capacities far beyond their sole engage-
ment as neurotrophins that was previously assigned to
them. They evolve as potent neuro-immunmodulators, non-
neuronal growth factors, and even as stress mediators in
various tissues, transgressing their role in the regulation of
nerve damage repair and peripheral neuronal plasticity (All-
eva and Santucci, 2001; Renz, 2001; Marshall and Born,
2002; Bayas et al, 2003). TrkB for example is expressed
by dendritic cells and macrophages in lymphoid organs
(Hannestad et al, 1998) and BDNF is expressed by T cells
(Barouch et al, 2000; Moalem et al, 2000). BDNF is also
required for the sustenance of corneal epithelial cells (You
et al, 2000) and the survival and proliferation of pigment
cells during neural crest development and in the retina
(Sieber-Blum, 1998; dos Santos et al, 2003), and may also
play a role in bone formation (Asaumi et al, 2000).
As a very densely innervated mini-organ, the hair follicle
is subject to life-long recurring tissue-remodeling events
(hair cycle) with alternating phases of rapid growth and
pigmentation (anagen), apoptosis-driven regression (cata-
gen), and relative quiescence (telogen). These tissue re-
modeling events during hair follicle cycling involve both the
organ itself (Stenn and Paus, 2001), its innervation (Botch-
karev et al, 1997, 1998b, 1999c; Peters et al, 2001), its
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vasculature (Mecklenburg et al, 2000), and profound chang-
es of the skin architecture and immune function (Paus et al,
1999a). BDNF expression in the murine hair follicle fluctu-
ates in a strikingly hair cycle-dependent manner and BDNF
overexpression causes premature catagen development
(Botchkarev et al, 1999a) and alters cutaneous innervation
density (Botchkarev et al, 1998b).
Since nervous system and hair follicle epithelium share a
common ectodermal origin, it is not surprising that TrkB is
also expressed by cutaneous epithelial cells in mice and
humans (Shibayama and Koizumi, 1996; Botchkarev et al,
1999a, b). In regressing hair follicles of C57BL/6 mice, TrkB
is expressed on apoptotic keratinocytes during catagen and
BDNF skin content is highest during anagen–catagen trans-
formation (Botchkarev et al, 1999a). Simultaneous expres-
sion of BDNF by these cells suggests para- and autocrine
growth-regulatory effects of BDNF on epithelial tissues
(Shibayama and Koizumi, 1996; Botchkarev et al, 1999a).
Although epidermal keratinocyte proliferation is stimulated
by BDNF (Botchkarev et al, 1999b), a growth-inhibitory ef-
fect of BDNF on selected keratinocyte subpopulations was
demonstrated with the report that BDNF induces premature
catagen development in anagen hair follicles of C57BL/6
mice (Botchkarev et al, 1999a).
Given the very substantial inter-species differences that a
given bioregulatory compound can exert, e.g. on murine
versus human hair follicles (cf. Paus and Cotsarelis, 1999;
Stenn and Paus, 2001) and the contrasting effects of BDNF
on epidermal (stimulation of proliferation) (Botchkarev et al,
1999b) and hair follicle keratinocytes (promotion of apop-
tosis) (Botchkarev et al, 1999a) in mice, it remains totally
unknown whether BDNF/TrkB signaling plays any role in
human hair biology. With these limitations in mind, we have
addressed the following specific questions:
1. Do human hair follicle keratinocytes and fibroblasts in
normal scalp skin express BDNF and/or its high-affinity
receptor TrkB mRNA and immunoreactivity (IR)?
2. Does BDNF promote catagen development in organ-
cultured human anagen hair follicles, as it does in mice?
3. If so, does this include the recruitment of recently rec-
ognized common mechanisms of catagen induction
in human hair follicles, such as downregulation of hair
follicle keratinocyte proliferation, upregulation of kera-
tinocyte apoptosis, and transforming growth factor b
(TGFb)-mediated catagen induction?
4. Can negative BDNF effects on human hair growth in vitro
be antagonized?
These questions were addressed by analyzing the ex-
pression pattern of BDNF and TrkB in human scalp skin
biopsies as well as in isolated anagen VI hair follicles by
rtPCR analysis, in situ hybridization, and immunofluores-
cence. Analysis of human hair follicle cycling is difficult.
Most available hair follicles for rtPCR, in situ analyses, or
immunohistochemistry derive from scalp skin excised dur-
ing elective plastic surgery. In such biopsies, 80%–90% of
all hair follicles are in anagen VI, and the remainder are
in telogen, with catagen or early anagen hair follicles be-
ing detectable only extremely rarely (Paus and Cotsarelis,
1999). Therefore, in situ expression analyses of growth fac-
tors and receptors largely are limited to studying anagen VI
and telogen hair follicles. In addition, human anagen VI
scalp skin hair follicles were organ cultured (Philpott et al,
1994; Philpott, 1999) to investigate the impact of re-
combinant human BDNF (rhBDNF) or BDNF plus TGFb-
neutralizing antibodies on active hair shaft elongation and
maintenance of the hair shaft-producing unit in the anagen
hair bulb.
Results
Human anagen hair follicles express BDNF and TrkB
mRNA rtPCR revealed that micro-dissected human scalp
skin anagen hair bulbs, which include the hair follicle ep-
ithelium proximal to the isthmus and bulge region as well as
the dermal papilla and the proximal connective tissue
sheath of the hair follicle, contained transcripts of the BDNF
and TrkB genes (Fig 1). This offered an indication, that, just
like their murine counterparts, human anagen hair follicles
are both sources and targets of BDNF/TrkB-mediated
signalling.
BDNF mRNA is expressed both in the mesenchyme and
epithelium of human anagen VI hair follicles, TrkB only
in the epithelium (inner and outer root sheath) BDNF
and TrkB transcription in human scalp anagen VI hair fol-
licles was confirmed and localized by in situ hybridization
using fluorescein-labeled oligonucleotide probe (Fig 2). All
negative and positive controls (see Materials and Methods)
confirmed the specificity and sensitivity of the used in situ
stainings. Staining intensity for BDNF transcripts was
strongest in the proximal inner root sheath and distal out-
er root sheath (Fig 2), and BDNF transcript-related signals
were also detected in the dermal papilla. TrkB transcripts
were present in the proximal inner and distal outer root
sheath, but not in the dermal papilla (Fig 2).
Immunohistochemistry conﬁrms translation of BDNF
and TrkB mRNA in human anagen VI hair follicles BDNF
and TrkB translation in human scalp anagen VI hair follic-
les was confirmed by immunohistochemistry (Fig 2). All
Figure1
Brain-derived neurotrophic factor (BDNF) and tyrosine kinase B
(TrkB) are expressed in the human anagen hair follicle by rtPCR.
rtPCR analysis was performed on isolated human hair follicles using
primers for BDNF and TrkB. As positive control, RNA from full-thickness
temporal human scalp skin was used and water was used as negative
control.
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negative and positive controls confirmed the specificity and
sensitivity of the used immunohistochemical stainings: spe-
cific staining patterns were absent in negative controls
without primary antibody, or were strongly diminished after
preincubation with specific blocking peptide. Positive con-
trols showed the expected IR patterns in human pancreatic
epithelia (Miknyoczki et al, 1999). All extrafollicular IR pat-
terns were not analyzed in detail, since they are the subject
of a separate, ongoing study, and the schemes that sum-
marize BDNF and TrkB IR have only been sketched in pre-
liminary form (Fig 2).
Semiquantitative analysis of BDNF IR demonstrated
strongest protein expression in more differentiated keratin-
ocyte cell populations such as the proximal inner root
sheath and in the mesenchymal compartment, e.g. the der-
mal papilla. TrkB IR, in contrast, was strongest in more un-
differentiated keratinocyte cell populations such as the
basal layer of the hair follicle ostium. TrkB IR was also de-
tected in the hair matrix and proximal outer root sheath but
not in the dermal papilla (Table I).
Low BDNF and TrkB is present in the telogen hair fol-
licle Because of their low incidence in human scalp skin
(10%–20% of all hair follicles), telogen hair follicles were
detected only rarely in normal human scalp skin sections. In
13 (BDNF) and nine (TrkB) different donor samples (which
contained more than 40 anagen hair follicles), only four
telogen hair follicles, each of a different donor, were found
per investigated antigen. Hair follicles in catagen or early
anagen were not detected at all. Weakly positive BDNF
staining (IR and in situ) was detected in the outer root
sheath and secondary hair germ epithelium of all telogen
hair follicles (Fig 2). BDNF staining was pronounced in the
outer root sheath basal layer. TrkB staining was weak in the
hair follicle epithelium (Fig 2). Interestingly and in contrast to
our findings in anagen skin, in the telogen stage of the hair
cycle the dermal papilla-stained negative for both antigens
(Fig 2).
BDNF concentration dependently inhibits hair shaft
elongation in cultured human anagen hair follicles In
order to assess the functional relevance of BDNF/TrkB
signaling in the anagen hair follicle, microdisected lower
anagen hair follicles from normal human scalp skin were
cultured in the presence of 1, 5, 25, 50, and 150 ng per mL
rhBDNF. These experiments revealed a significant reduction
of hair growth in hair follicles cultured with 50 and 150 ng
per mL BDNF, whereby hair follicles treated with 150 ng
per mL exhibited dystrophic features such as pigment in-
continence as a sign of toxification. Therefore 50 ng per mL
was chosen for the treatment of a larger number of samples
(Fig 3).
Figure2
Brain-derived neurotrophic factor (BDNF)- and tyrosine kinase B
(TrkB)-expression patterns in human hair follicles. The schematic
summaries display the most highly reproducible BDNF and TrkB IR
patterns revealed in human anagen scalp skin hair follicles. Cryosec-
tions (immunohistochemistry [IHC]) or paraffin sections (in situ hybrid-
ization) from human scalp skin samples containing 80%–90% anagen
hair follicles were stained with antisera against BDNF and TrkB (Santa
Cruz Biotechnology) or were labeled with oligonucleotide probes to
BDNF or TrkB. All images demonstrate representative IR patterns in
anagen hair follicles and telogen hair follicles. If not otherwise labeled,
arrows point at strongly stained structures. Boxes indicate anatomical
location of the presented micrographs. The bottom panel gives exam-
ples of positive and negative controls. For the IHC-negative control, the
primary antibody was omitted and the secondary antibody was applied
(identical for BDNF and TrkB). The arrow points at the negative inner
root sheath, which would stain strongly with primary antibody. Pan-
creatic ductal adeno carcinoma served as positive controls for IHC.
Arrows point at strong staining. Pan-mRNA served as positive control
and omittance of probe as negative control for in situ. Again, arrows
point at the inner root sheath normally staining positive. ch, club hair;
d, dermis; dp, dermal papilla; e, epidermis; hfe, hair follicle epithelium;
hm, hair matrix; hs, hair shaft; irs, inner root sheath; ors, outer root
sheath; sc, subcutis.
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BDNF induces premature catagen development in vitro
Hair cycle staging of hair follicles treated with 50 ng per mL
rhBDNF after 48 h in culture did not show catage-like
development. First catagen-like hair follicles could be de-
tected after 96 h, whereas none were seen in control hair
follicles (not shown). This difference became highly signif-
icant after 10 d in culture with 50 ng per mL rhBDNF (Fig 4).
BDNF upregulates apoptosis and inhibits proliferation
of human hair follicle keratinocytes in situ Quantitative
histomorphometry of terminal deoxynucleotidyl transferase
(TdT)-mediated dUTP-biotin Nick end labeling (TUNEL) or
Ki67 IR nuclei in organ-cultured human hair bulbs revealed
significantly less Ki67þ , proliferating keratinocytes in hair
follicles treated for 10 d with 50 ng per mL rhBDNF when
compared with controls (Fig 5). Complementary hair follicles
showed significantly more TUNELþ cells after 10 d of cul-
ture with 50 ng per mL rhBDNF (Fig 5). Quantitative TUNEL/
Ki67 histomorphometry of hair follicles harvested after only
2 or 4 d of culture did not show significant differences (not
shown).
BDNF upregulates TGFb2 gene transcription in human
anagen hair follicles To investigate possible signaling
loops recruited by BDNF in the control of catagen induc-
Table I. Summary of BDNF and TrkB staining intensities in
various compartments of anagen VI scalp skin hair follicles
BDNF TrkB
mRNA Protein mRNA Protein
Hair follicle ostium þ þ þ þ þ þ a
Inner root sheath þ þ þ þ þ þ þ þ þ
Outer root sheath
(including the isthmus and
bulge region)
þ þ þ þ þ þþ þ
Proximal hair follicle bulb þ þ þ þ
Hair matrix (þ ) (þ ) (þ ) 0
Cuticle of the hair shaft 0 0 þ þ
Dermal papilla þ þ þ þ 0 0
The table lists the mean staining intensities from nine (TrkB) or 13
(BDNF) different human scalp skin samples. From each sample ten mi-
croscopic fields or six hair follicles were evaluated and assigned arbitrary
scores (þ , weak; þ þ , obvious staining; þ þ þ , strong staining).
aBasal layer, rest is þ like epidermis.
BDNF, brain-derived neurotrophic factor; TrkB, tyrosine kinase B.
Figure 3
Brain-derived neurotrophic factor (BDNF) reduces hair shaft elon-
gation in organ culture. On the left, photodocumentation panels over
a culture period of 10 d of one characteristic hair follicle per group are
given. On the right, data pooled from six highly comparable, inde-
pendent experiments (nine hair follicles per experiment, only pigmented
hair follicles included) are shown. Growth rates are expressed as per-
cent difference over day 0. Significances always refer to the growth rate
of control hair follicles on the same day (p-values by Mann–Whitney U:
þ þ þo0.001, þo0.05).
Figure4
Fifty nanograms per milliliter recombinant human brain-derived
neurotrophic factor (rhBDNF)-induced catagen after 10 d in cul-
ture. This figure shows characteristic examples of photodocumented
hair follicles cultured over 10 d and corresponding H&E-stained cryo-
sections. Note the wide anagen hair bulb of the control hair follicle (left).
In comparison, the hair bulb of a hair follicle treated with 50 ng per mL
rhBDNF appears narrow, the dermal papilla has rounded up, and the
hair follicle epithelium is not enclosing it. The graph represents data
pooled from four highly comparable independent experiments (nine hair
follicles per experiment). Data are represented as percentage hair fol-
licles in anagen VI, early or late catagen, respectively, or as hair cycle
score. Each anagen VI hair follicle was ascribed an arbitrary value of
100, early catagen like of 200, mid-catagen like of 300, and late cata-
gen like of 400 to calculate the hair cycle score. Values were added per
group and divided by the number of staged follicles. The score thus
represents the mean hair cycle stage of all hair follicles per group.
Significances refer to the hair cycle score of control hair follicles on the
same day (p-values by Mann–Whitney U: þ þ þo0001, þ þo0.01,
þo0.05). c, club; dp, dermal papilla; hs, hair shaft; irs, inner root
sheath, ors, outer root sheath; pu, pigmentary unit.
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tion, we performed quantitative real-time rtPCR analysis of
TGFb2 steady-state mRNA levels in hair bulbs, since TGFb2
is now appreciated as a key catagen-promoting growth
factor in the human system (Soma et al, 2002; Tsuji et al,
2003; Hibino and Nishiyama, 2004). This showed substan-
tial upregulation of TGFb2 mRNA in hair bulbs that were
cultured in the presence of 50 ng per mL rhBDNF over 48 h
(Fig 6).
TGFb-neutralizing antibodies abrogate BDNF-induced
inhibition of hair shaft elongation Simultaneous treat-
ment of cultured human anagen hair follicles with 50 ng per
mL BDNF and 10 (not shown) or 25 (Fig 7) mg per mL TGFb-
neutralizing antibodies completely abrogated the catagen-
inductive and anti-proliferative effects of 50 ng per mL
rhBDNF, e.g. hair shaft elongation rates did not differ from
controls after 4 d in culture, when rhBDNF inhibition of hair
shaft elongation became significantly different from control
(Fig 7). Likewise, hair cycle staging, apoptosis (TUNEL), and
proliferation analysis (Ki67) on hair follicles cultured over
4 or 10 d revealed anagen to early catagen hair bulbs with
high numbers of Ki67þ proliferating and low numbers of
TUNELþ apoptotic keratinocytes in the control as well as
the groups treated with BDNF together with TGFb-neutral-
izing antibody (not shown). Hair follicles that were treated
with 50 ng per mL rhBDNF showed striking upregulation of
TGFb2 expression in the hair bulb by immunohistochemistry
especially in the hair follicle matrix, the inner root sheath,
and the outer root sheath (Fig 7), whereas TGFb2 expres-
sion was restricted to the most differentiated layer of the
inner root sheath in control hair follicles and hair follicles
treated with 50 ng per mL BDNF and 25 mg per mL TGFb-
neutralizing antibodies.
Discussion
Since it was first shown in mice that mammalian skin and
especially keratinocytes may be a source for neurotrophins
(Tron et al, 1990), a body of data has accumulated, in sup-
port of the concept that the skin epithelium is also an im-
portant target of neurotrophin signaling (Paus et al, 1994b;
Pincelli and Yaar, 1997; Botchkarev et al, 1999a, b; Lambi-
ase et al, 2000). More recently, our own studies have high-
lighted that neurotrophins are prominently involved in the
control of murine hair follicle development and cycling and
that the murine hair follicle is actually a prominent source of
neurotrophins (Botchkarev et al, 1998a, c, 1999a, b, 2000).
In this investigation on BDNF signaling in human hair growth
control, we now show that selected neurotrophins act as
hair growth regulators in the human system as well, e.g.
via high-affinity tyrosinekinase receptors such as TrkB, and
that the human hair follicle is both a source and target of
neurotrophins. This underscores their importance in
Figure 5
Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin
Nick end labeling (TUNEL)/Ki67 double staining analysis on hair
follicles cultured over 10 d. Per experiment harvested on day 10 after
onset of culture, one to four of nine hair follicles allowed quantification
of TUNEL (green) or Ki67 IR (red) nuclei. Only analysis of apoptosis and
proliferation in keratinocytes yielded significant differences. Signifi-
cances always refer to control levels (p-values by Mann–Whitney U:
þo0.05). Please note the numerous TUNEL IR terminally differentiating
cell nuclei in the hair shaft. cs, connective tissue sheath; dp, dermal
papilla; hs, hair shaft. Arrowheads point at TUNELþ nuclei.
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Figure6
Brain-derived neurotrophic factor (BDNF) increases tumor growth
factor b2 (TGFb2) transcription. Nine human hair follicles were cul-
tured with or without 50 ng per mL BDNF over 48 h. Proximal (lower)
portions were collected with surgical scalpels after the culture. The
expression of TGFb2 was measured by quantitative real-time PCR
(TaqMan PCR) and normalized with GAPDH expression. Each PCR re-
action was performed in triplicate. Graphs represent pooled date from
these triplicates. Significance refers to control levels (p-values by
Mann–Whitney U: þ þ þo0.001, þ þo0.01, þo0.05).
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cutaneous biology and further supports that neurotrophins
are important hair growth-modulatory agents in hair growth
control across species barriers:
1. The distribution of BDNF and TrkB in human scalp skin
hair follicles suggests auto- and/or paracrine BDNF ac-
tivities within the human hair follicle:
a. paracrine activities and mesenchymal–epithelial
cross-talk between BDNF-expressing fibroblasts in
the anagen dermal papilla on the one hand, and
TrkBþ hair follicle keratinocytes on the other.
b. para- and/or autocrine-signaling activities of BDNF
within the hair follicle epithelium expressing BDNF
and TrkB on gene and protein expression level.
c. suggestive involvement of BDNF in the autonomous,
intrafollicular control of follicle cycling because of the
hair cycle-dependent changes in BDNF expression in
the mesenchymal ‘‘command center’’ of the hair fol-
licle, i.e. the dermal papilla, between anagen VI
(present) and telogen (absent) (Paus et al, 1999b;
Stenn and Paus, 2001).
2. This is supported by the observation that BDNF inhibits
hair shaft elongation and promotes catagen develop-
ment in organ-cultured human anagen VI hair follicles,
and suggests that BDNF functions rather as a terminally
differentiation-promoting factor than as a growth factor
in human scalp hair follicles.
3. In line with this concept, higher doses of BDNF inhibit
hair follicle keratinocyte proliferation and stimulate ex-
pression of the catagen-promoting and keratinocyte
proliferation-inhibiting factor TGFb2.
4. That BDNF effects on human hair growth in vitro can be
antagonized by pan-TGFb-neutralizing antibodies sug-
gests that TGFb-mediated pathways along BDNF/
TrkB signaling serve at least as one important cellular ‘‘se-
cond messenger’’ system in the regressing human hair
follicle.
The expression pattern of BDNF and TrkB in human
scalp skin hair follicles in anagen VI and telogen shown here
is similar to the expression patterns described in mice and
rats with low expression during the resting phase (telogen)
and high expression in the high growth phase (anagen VI)
(Botchkarev et al, 1998b, 1999b, 2000; Bergman et al,
2000), suggesting a parallel function of BDNF in murine and
human hair growth regulation. Here, we can confirm this
hypothesis by showing that exogenous BDNF does indeed
cause premature catagen development of organ-cultured
human anagen hair follicles as does BDNF overexpression
in mice (Botchkarev et al, 1999a).
Figure7
Tumor growth factor b (TGFb)-neutralizing
antibody abrogates Brain-derived neu-
rotrophic factor (BDNF)-induced inhibi-
tion of hair shaft elongation. On the left,
data pooled from three independent exper-
iments (nine hair follicles per experiment;
only pigmented hair follicles were included)
are shown. Growth rates are expressed as
percent difference over day 1. Significances
always refer to the growth rate of control and
recombinant human BDNF (rhBDNF)/TGFb-
neutralizing antibody treated hair follicles on
the same day (p-values by Mann–Whitney U:
þ0.05). On the right, representative photo-
micrographs are shown of TGFb2 immuno-
reactivity in control hair follicles (top row),
hair follicles treated with 50 ng per mL
rhBDNF, and 25 ng per mL TGFb-neutraliz-
ing antibody, and hair follicles treated with
50 ng per mL rhBDNF (bottom row). The left
column shows immunofluorescence micro-
graphs; the right column shows inverted mi-
crographs for better anatomical orientation.
dp, dermal papilla; hs, hair shaft; hm, hair
matrix; irs, inner root sheath; ors, outer root
sheath.
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Catagen hair follicles are only rarely detected in human
scalp skin samples; we therefore cannot provide data on
TrkB expression of apoptotic cells in the regressing hair
follicle as are seen in the mouse. In the mouse, the high-
affinity BDNF-receptor TrkB is upregulated during catagen
and co-localizes with markers of apoptotic cell death in the
epithelium of the regressing hair bulb (Botchkarev et al,
2000). The promoting effect of BDNF on apoptosis-driven
catagen development in the human anagen hair follicle may
thus occur via BDNF secretion of the dermal papilla and/or
more differentiated keratinocytes in the hair follicle, acting
on TrkBþ hair follicle keratinocytes initially in the inner and
outer sheath and upon catagen onset in the upregulating
hair bulb.
In this context, it is crucial to understand that neu-
rotrophins utilize more than one mode of interaction with
their receptors (Lopez-Sanchez and Frade, 2002): acting as
high-affinity growth factors activated by low concentrations
of neurotrophins (Yaar et al, 1994; Barker, 1998; Roux and
Barker, 2002), activation of Trk receptors by high levels of
neurotrophins has been shown to induce apoptosis de-
pending on receptor availability and receptor density (cf.
Roux and Barker, 2002). Apoptosis through the common
low-affinity neurotrophin receptor p75, a member of the
TNF-receptor family leading to rapid apoptosis of the ex-
pressing cells, is another possible pathway involved in
BDNF-mediated hair follicle regression (Botchkarev et al,
2000) and is the subject of an ongoing study on neurotro-
phin signaling in human hair growth control through this re-
ceptor (Peters et al, 2005).1 Moreover, careful examination
for morphological indicators of toxicity (see Materials and
Methods) did not reveal any evidence that the hair growth-
inhibitory effects of BDNF presented here were related to
hair follicle toxicity.
In our model, BDNF was also able to upregulate the ker-
atinocyte differentiation factor TGFb2 (Min et al, 1999;
Hashimoto, 2000; Amendt et al, 2002) in the hair bulb as
early as 48 h after start of culture. The observed TGFb2 IR
pattern in hair follicles treated with 50 ng per mL BDNF is in
good accordance with the expression pattern observed by
others during progression of the hair cycle and induction of
catagen (Soma et al, 2002). Moreover, in our study hair
growth could be maintained by co-administration of BDNF
with anti-TGFb1, 2, and 3-neutralizing antibodies. These
observations suggest that TGFb2, known to be a potent
catagen inducer in murine (Foitzik et al, 2000) and human
hair follicles (Philpott et al, 1994; Soma et al, 1998; Inui et al,
2002; Soma et al, 2002, Tsuji et al, 2003; Hibino and Nishi-
yama, 2004), is at least one major player in BDNF-induced
premature catagen development. As evidenced by our
functional experiment utilizing a pan-TGFb-neutralizing an-
tibody, TGFb1 or 3 may also contribute to the BDNF-in-
duced premature catagen development observed in our
experiments. But TGFb2 was shown to be a more potent
catagen inducer in human scalp hair follicles than TGFb1
(Soma et al, 1998, 2002; Tsuji et al, 2003; Hibino and Ni-
shiyama, 2004). Furthermore, to the best of our knowledge,
no effect of BDNF has previously been reported on TGFb3
expression, and TGFb3 is widely considered to be of neg-
ligible importance in both human and murine hair growth
control since there is no published evidence to support any
such role (cf. Soma et al, 1998, 2002; Foitzik et al, 1999;
Stenn and Paus, 2001).
In glial astrocytes, BDNF can induce cell cycle arrest
proteins such as p53 (Jordan-Sciutto et al, 2001) and in
corneal keratinocytes, BDNF promotes differentiation as
shown by colony formation but not proliferation (You et al,
2000). Together with our findings of TGFb upregulation in
unison with catagen induction and reduced keratinocyte
proliferation by BDNF presented here, these observations
led us to the hypothesis that BDNF/TrkB signaling in the
context of the growing human hair follicle promotes terminal
differentiation rather than proliferation directly and indirectly,
e.g. by modulating other growth factor-mediated pathways.
Our findings support an important role for BDNF as a
trophic factor outside neural networks in the human and
suggest to further use the cultured human hair follicle as an
easily accessible and all the while complex miniature organ-
culture system for future analysis of neurotrophins in epi-
thelial and mesenchymal growth control. Local BDNF has
been applied, with few side effects to patients suffering
from diabetic polyneuropathy (Wellmer et al, 2001). There-
fore, the topical application of TrkB agonists or the upreg-
ulation of endogeneous BDNF production in terminal
anagen hair follicles may be useful future tools in the man-
agement of unwanted hair growth (hirsutism), whereas the
local application of specific TrkB antagonists not yet avail-
able holds promise for the future management of telogen
effluvium in human.
Materials and Methods
Tissue and hair follicle sources Temporal scalp skin containing
mainly anagen VI hair follicles was obtained from disposed excess
skin samples derived from patients undergoing elective plastic
surgery after obtaining informed consent, following accepted ethic
guidelines of the University of Hamburg, Germany. The study was
conducted according to the Declaration of Helsinki Principles. After
excision, tissue was maintained in Williams E Medium (Biochrom
KG seromed, Berlin, Germany) for transportation at 41C up to 24 h.
Upon arrival, the samples were divided by three: one part was
immediately snap-frozen in liquid nitrogen for immunohistochem-
ical analysis, the second was processed for paraffin embedding to
allow routine hair follicle staging and in situ hybridization, and the
third was processed for rtPCR and quantitative real-time rtPCR
analysis and hair follicle culture as described below.
Conventional rtPCR analysis Single human anagen VI hair
follicles were microdisected from human skin biopsies. Micro-
disected hair follicles consisted of the hair bulb and the distal
hair follicle, up to the level where the arector pili muscle inserts into
the bulge region (including the hair shaft, the inner and outer root
sheath, the connective tissue sheath, and the dermal papilla). RNA
was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germa-
ny). 0.8 mg of total RNA was reverse transcribed using the first
Strand cDNA Synthesis Kit for rtPCR (Roche, Mannheim, Germany)
in an oligo-d(T)15-primed 20 mL reaction. rtPCR was carried out
using the Core PCR Kit (Qiagen) in 25 mL reactions containing 1 mL
cDNA, 2.5 mM MgCl2, 200 mM dNTP, 0.5 U Taq polymerase, and
0.5 pmol of each primer. The following oligonucleotide primers
were designed to amplify target cDNA. 50-TCCACCAGGTGAGAA-
1Peters EMJ, Hansen M, Overall R, Pertile P, Arck PC, Klapp BF,
Paus R: p75, a brake on life and death decisions in human hair
growth control, 2005, in preparation
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GAGTG-30 and 50-ACTTGACTACTGAGCATCAC-30 to amplify a 319
bp fragment corresponding to nucleotides 277–595 of BDNF
mRNA (Genbank: X60,201), and 50-ATGCTGTGGTGGTGATTGCG-
30 and 50-CCTTTCATGCCAAACTTGGAGTGTC-30 to amplify a 97
bp fragment corresponding to nucleotides 1652–1748 of the TrkB
mRNA (Genbank: U12,140 common to all known isoforms of TrkB).
The reactions were run in a thermal cycler (PE Biosystems, Foster
City, California) for 5 min at 951C, then 30 s at 951C, 30 s at 601C,
45 s at 721C for 35 cycles, and then 5 min at 721C. Products were
run on a 1% agarose gel (Sigma, St Louis, Missouri). The identity of
the products was confirmed by sequencing.
Quantitative real-time rtPCR analysis Hair follicles cultured over
48 h in the presence of 50 ng per mL rhBDNF (for details, see Table
II) were dissected into proximal region consisting of the hair bulb
and distal region consisting of the hair shaft and inner and outer
root sheaths with the adjacent connective tissue sheath with a
surgical scalpel under a microscope. Snap-frozen proximal hair
follicle regions were homogenized with a glass homogenizer (neo-
Lab, Heidelberg, Germany) and processed as described above.
Amplification reactions were performed as 50 mL triplicates in a 96-
well microplate format containing 1  SYBR Green Master Mix (PE
Biosystems), first strand cDNA, and each primer set. Primers were
designed using the Perkin Express 1.0 Software (PE Biosystems)
and each set of primers are situated in different exons as human
TGFb2 50-AAAGTGGACGTAGGCAGCAATTA-30 forward primer,
human TGFb2 50-GACCAACCGGCGGAAGA-30 reverse primer,
human glyceraldehydes-3-phosphate dehydrogenase (GAPDH) 50-
TGGGTGTGAACCATGAGAAG-30 forward primer, and human GAP-
DH 50-GCTAAGCAGTTGGTGGTGC-30 reverse primer, respectively.
The reaction mixture was subjected to the following thermal cycle
conditions: 501C for 2 min, 951C for 10 min and 40 cycles of 15 s at
951C, and 1 min at 601C. Analysis of the reactions was carried out
in an ABI Prism 7700 Sequence Detection System (PE Biosystems)
monitoring after each cycle. The expression of TGFb2 was nor-
malized with that of GAPDH. Each TaqMan experiment was per-
formed in triplicate.
In situ hybridization Oligonucleotide probes to TrkB (Genebank:
AF410,899 50-GAT TGC CCA CCA GGA TCA GTT CAG ACA AGT-
30) and BDNF (Genebank: M61,176 50-ATG ATG TCA AGC CTC
TTG AAC CTG CCT TG-30), labeled with fluorescein at both the 30
and 50 ends, were obtained from Biognostik (Go¨ttingen, Germany;
designed and used as recommended by vendor, Biognostik). Four
micrometer paraffin sections of human skin were dewaxed and
rehydrated before being treated with 50 mg per mL proteinase K
(Roche) in proteinase K buffer (50 mM Tris, pH 7.5, 10 mM EDTA,
10 mM NaCl) for 15 min at 371C. Sections were then post-fixed for
10 min with 1% paraformaldehyde in PBS (0.68 M NaCl, 26.82 mM
KCl, 17.64 mM KH2PO4, 0.10 M Na2HPO4, pH 7.4) followed by
washes in PBS and water for 10 min each. Sections were then
prehybridized in hybridization buffer (2  SSC (0.15 M NaCl, 0.015
M sodium citrate, pH 7.0), 5 mg yeast tRNA (Sigma, Taufkirchen,
Germany), 150 mM NaCl, 50% formamide) for 2 h at 301C. Hy-
bridization was carried out for 16 h at room temperature (251C) with
1.5 pmol probe in the hybridization buffer. Following hybridization,
excess unbound probe was washed off by a brief rinse followed by
two washes for 15 min each with 0.1  SSC at 371C. Sections
were then equilibrated in TN buffer (pH 7.5, 100 mM Tris, pH 7.5,
150 mM NaCl) for 5 min before being incubated with blocking
solution (TN (pH 7.5) containing 0.1% Triton-X 100% and 1% nor-
mal goat serum) for 30 min at 371C. The blocking solution was
then replaced with antibody (anti-fluorescein AP FAB fragments
(Roche)) diluted 1:1000 in blocking solution, and the sections were
incubated for another 1 h at 371C. The slides were then washed
twice in TNT (100 mM Tris, pH 7.5, 200 mM NaCl, 0.1% Tween-20)
for 15 min each time, and then equilibrated in TN (pH 9.5, 100 mM
Tris, pH 9.5, 150 mM NaCl) for 5 min. Sections were then incubated
in the dark with color solution (TNM (100 mM Tris, pH 9.5, 100 mM
NaCl, 50 mM MgCl2) to which 20 mL NBT/BCIP mix (Roche) had
been added directly before use) for 3  1 h, with sections rinsed in
TN (pH 9.5) and a fresh color solution added each hour.
Immunohistochemistry Cryostat sections (8 mm) of human scalp
skin, fixed in acetone (at 201C, 10 min), were preincubated with
10% normal goat serum (20 min, room temperature) and then in-
cubated overnight at room temperature with the primary antisera to
BDNF, TrkB, or TGFb2 (BDNF; rabbit, polyclonal, raised against
AA 128–147 mapping at C-terminus of h-BDNF; Santa Cruz Bio-
technology, Santa Cruz, California; cf. Lommatzsch et al, 1999;
Botchkarev et al, 1999a, b; diluted 1:50; n¼ 14. BDNF; mouse,
monoclonal, raised against rhBDNF; Sigma, St Louis, MI, USA;
diluted 1:200; n¼ 5. TrkB; rabbit, polyclonal, raised against AA
794–808 mapping at the C-terminus of TrkB gp 145; Santa Cruz
Biotechnology; cf. Lommatzsch et al, 1999; Botchkarev et al,
1999a, b; diluted 1:75; n¼ 9. TGFb2; rabbit, polyclonal, raised
against peptide mapping at the C-terminus of TGFb2 of human
origin; Santa Cruz Biotechnology; cf. Lyall et al, 2001; diluted
1:100; n¼ 4). For BDNF we found two working antibodies yielding
comparable staining results, which mapped different epitopes of
BDNF. For TrkB only antibodies mapping the same epitope were
commercially available. Working BDNF and TrkB antibodies were
available from Santa Cruz Biotechnology; we therefore chose
these for immunoflourescence screening of all available skin sam-
Table II. Hair follicle organ-culture treatment schedules
Treatment
Duration of
culture Number of donors Processed for
A 5 or 50 ng per mL rhBDNF 10 d 11 different donors Seven for hair shaft elongation; four for proliferation,
staging analysis, TGFb2 immunohistochemistry;
eight for apoptosis analysis
Aa 50 ng per mL rhBDNF 96 h One donor Apoptosis/proliferation and staging analysis
Ab 50 ng per mL rhBDNF 48 h Two different donors One for apoptosis/proliferation and staging analysis,
one for TGFb2 rtPCR
B 5, 10, 25, 50, 150 ng per mL rhBDNF 10 d Five different donors Hair shaft elongation
C 5 and 50 ng per mL anti-BDNF 10 d Eight different donors Hair shaft elongation, two for apoptosis/proliferation
and staging analysis
D 5, 10 or 25 mg per mL anti-TGFb 250
ng per mL rhBDNFþ
96 h Three different donors Apoptosis/proliferation and staging analysis, TGFb2
immunohistochemistry
Each donor also contributed to controls.
rhBDNF, recombinant human brain-derived neurotrophic factor; TGFb2, transforming growth factor b2.
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ples. All anti-sera were supplemented with 2% normal goat serum.
This was followed by an incubation of 45 min at room temperature
with tetramethylrhodamine-isothiocyanate-conjugated F(ab)2
fragments of goat anti-rabbit or goat anti-mouse IgG (Dianova,
Hamburg, Germany) diluted 1:200 in Tris-buffered saline (TBS).
Incubation steps were interspersed by three washes with TBS (5
min each). Then sections were stained with 40,6-diamidin-20-phe-
nylindol-dihydrochlorid (DAPI, Boehringer Mannheim, Mannheim,
Germany) with a concentration of 1 mg per mL (1 min, room tem-
perature) for identification of cell nuclei.
Two types of negative controls were run: (a) slides were incu-
bated with the secondary antibody alone; (b) slides were incubated
with a mixture (incubated overnight at 41C in tubes covered with
1% milk powder in TBS) of the primary antibody, and the control
peptide for the specific anti-sera (Santa Cruz Biotechnology, 5 and
10 and 20 times higher concentrated than primary antibody, over-
night, room temperature) after preincubation with 10% normal goat
serum.
As positive controls, cryopreserved samples from human pan-
creatic ductal adenocarcinoma (Miknyoczki et al, 1999) were kindly
supplied by Prof. Kalthoff (Molecular Oncology, Department of
Surgery, University of Kiel, Germany) and Dr Hosch (Department of
Surgery, University Hospital Hamburg-Eppendorf, Germany).
Histomorphometry A minimum of six sections of nine (TrkB) or 14
(BDNF) scalp skin samples, each derived from a different donor,
were examined at  250 magnification under a Zeiss Axioscope 2
fluorescence microscope using appropriate filters (Zeiss, Go¨ttin-
gen, Germany). IR was assessed by histomorphometry in defined
compartments such as the hair follicle ostium (hair follicle epithe-
lium between the epidermis and entry of the sebaceous gland into
the hair canal), inner root sheath, outer root sheath, cuticle, dermal
papilla, matrix, and proximal hair bulb epithelium (below Auber’s
line; for details on these follicle compartments, see Mu¨ller-Ro¨ver
et al, 2001). Intensity was recorded in a semi-quantitative manner
by ascribing arbitrary units to different staining intensities (0, neg-
ative; þ , barely visible staining; þ þ , apparent staining; þ þ þ ,
strong staining). For each IR pattern, follicular compartments were
evaluated in at least six different anagen hair follicles per sample
and the extrafollicular compartments in a minimum of ten micro-
scopic fields. The photodocumentation was carried out with the
help of a modular imaging program (Openlab, improvision, Hei-
delberg, Germany). The results of the observed, representative IR
patterns were also recorded qualitatively in schematized recording
protocols.
Hair follicle organ culture Normal human scalp skin hair follicles
in the anagen VI stage of the hair cycle (Mu¨ller-Ro¨ver et al, 2001)
were isolated following the protocol published by Philpott et al
(1994) and Philpott (1999) with slight modifications. Briefly, after
separation of the epidermis and dermis from subcutaneous fat
under a binocular dissecting microscope, the proximal two-thirds
of anagen hair follicles located in the subcutaneous fat were iso-
lated using watchmakers forceps and subsequently collected in
Petri dishes containing complete hair follicle culture medium (Will-
iams E, Biochrom KG seromed); 1% penicillin–streptomycin (Life
Technologies, Eggenstein, Germany); 1% L-glutamine 200 mM (Life
Technologies); 0.02% hydrocortisone (Sigma, Taufkirchen, Germa-
ny); and 0.1% insulin (Sigma). Three hair follicles per well were then
randomly distributed and cultured in 24-well plates (Costar,
Bremen, Germany) containing 500 mL of complete hair follicle cul-
ture medium per well.
Per experiment, a minimum of three wells (containing three hair
follicles each) was assigned to each test group, and was supple-
mented with different concentrations of rhBDNF (Promega, Woods,
Wisconsin) or rhBDNF with TGFb-neutralizing antibody (mono-
clonal anti-TGFb1–3 antibody (R&D Systems, Weisbaden, Ger-
many); binds to all three TGFb isoform (Roberts et al, 1985;
Cheifetz et al, 1990). An equal number of control follicles were
cultured in complete hair follicle culture medium alone. Each ex-
periment was repeated with hair follicles from different donors (for
details see Table II).
Every second day, each well was photodocumented, the total
length of each hair follicle was measured, medium was replaced,
and fresh supplements were added. After 2, 4, or 10 d hair follicles
were snap-frozen in a drop of OCT Cryochrome (Shandon, Pitts-
burgh, Pennsylvania) and stored at –801C until cryosectioning.
Hair cycle staging Cultured hair follicles were staged after 2, 4,
and 10 d (for detail see Table II) in culture, either by morphometric
evaluation of entire hair follicles photodocumented by inversion
light microscopy or by routine H&E histomorphometry, following
previously published hair cycle staging guidelines for the murine
hair cycle (Mu¨ller-Ro¨ver et al, 2001) and morphological character-
istics of the human hair cycle (Kligman, 1959).
Macroscopically, hair follicles were classified as anagen VI if the
hair bulb was wider than the rest of the hair follicle, the dermal
papilla was partially covered by melanin, and if the pigmented hair
shaft was emerging directly from the hair follicle pigmentary unit in
the precortical hair matrix. Histologically, anagen VI hair follicles
show a narrow, elongated, oval-shaped dermal papilla of loose
consistency, which is fully enclosed by the hair bulb keratinocytes,
residing in an onion-shaped, large hair bulb. Hair follicles were
classified as ‘‘early catagen’’ if the hair bulb was more narrow, i.e.
had essentially the same diameter as the rest of the hair follicle, if a
slightly condensed, tear-drop-shaped dermal papilla was visible, if
the pigmented zone of the hair shaft was beginning to retract in the
distal direction from the pigmentary unit, and/or if the number of
visible melanin granules in the distal hair bulb was substantially
decreased, compared with high anagen. Hair follicles were clas-
sified as being in ‘‘mid-catagen’’ when melanin granules were al-
most absent from the hair bulb and if, on longitudinal sections, the
bulb appeared opened at its proximal end, with a compact, ball-
shaped dermal papilla. Hair follicles were classified as being in
‘‘late catagen’’, if the hair bulb had become narrower than the distal
rest of the cultured hair follicle, if the dermal papilla was clearly
visible in an unpigmented hair bulb, yet was further condensed
compared with mid-catagen, and if the proximal part of the pig-
mented hair shaft was fully separated from the dermal papilla.
Histologically, these late catagen hair follicles display an epithelial
strand, a column of epithelial cells between the compact dermal
papilla and the germ capsule (secondary hair germ) (Mu¨ller-Ro¨ver
et al, 2001), the likely seat of epithelial stem cells from which the
hair matrix is reconstructed during the subsequent anagen stage
(Panteleyev et al, 2001). Furthermore, late catagen hair follicles
have already developed the so-called club hair, the hair shaft of
follicles in the ‘‘resting’’ stage (telogen), whose proximal end is
unpigmented and appears separated from the dermal papilla.
In addition to hair cycle staging, signs of hair follicle dystrophy
such as extraepithelial pigment (melanin incontinence), ectopic lo-
calization of melanin granules in the hair bulb (Paus et al, 1994a;
Tobin et al, 1998), or hair shaft kinking were also documented.
For statistical analysis (hair cycle score [HCS]), anagen VI hair
follicles were arbitrarily attributed a score of 100, hair follicles in
early catagen a score of 200, in mid-catagen of 300, and in late
catagen of 400. The sum of scores per group was than divided by
the number of investigated hair follicles (Maurer et al, 1997; Peters
et al, 1999). The mean value of these scores therefore is a reliable
quantitative indicator of the mean hair follicle stage that had been
reached on average by a larger population of hair follicles after
culture (Maurer et al, 1997; Peters et al, 1999).
Apoptosis/proliferation assay Cryostat sections of cultured hair
follicles were processed for TUNEL labeling (apoptotic cell nuclei)
and Ki67 labeling (proliferating cell nuclei) after 2, 4, or 10 d (for
detail, see Table II) according to our previously published protocol
(Lindner et al, 1997) adapted for human antigens. The TUNEL as-
say detects DNA fragmentation by enzymatic labeling of free 30-OH
ends according to the manufacturer’s instructions (Apopdetect
Fluorescein, QBiogene, Heidelberg, Germany). Subsequently, sec-
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tions were incubated with mouse anti-human Ki67 antiserum
(anti-human Ki67 antigen, monoclonal, mouse, DAKO, Hamburg,
Germany), detected by a rhodamine-conjugated goat anti-mouse
antibody. Cell nuclei were counterstained with DAPI as described
above. For negative controls, the TdT-enzyme step was omitted.
Hair bulbs were photo-documented at  250 magnification
with a Zeiss Axioscope 2 fluorescence microscope, and IR nuclei
were counted in individual hair follicles in the following tissue
compartments: epithelial bulb (hair growth effects of culture con-
ditions), the dermal papilla, and the surrounding connective tissue
sheath of all hair follicles (toxic effects of culture conditions), which
allowed full appreciation of a longitudinal-sectioned dermal papilla
(since this is very difficult to achieve, the total number of hair bulbs
analyzed was restricted to 9–16 hair bulbs per group).
Statistical analysis The HCS was assessed and calculated as
described (Maurer et al, 1997; Peters et al, 1999). Scores, TUNEL
IR, and Ki67 IR cell nuclei numbers were pooled per group for each
experiment. The results between different experiments using sam-
ples from different donors were highly comparable so that the
mean scores and numbers of TUNEL IR or Ki67 IR cell nuclei per
group and experiment from all experiments were then pooled again
and statistical differences between groups were determined by the
Mann–Whitney U test for unpaired samples.
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